Naloxone-Induced Acute Opioid Withdrawal in a Stabilized Extended-Release Naltrexone-Treated Patient.  Spitzberg AJ, Urner EM, Wirshing WC.  Prim Care Companion CNS Disord. 2020 Sep 17;22(5):20l02590. doi: 10.4088/PCC.20l02590. PMID: 329…

Improving naltrexone compliance and outcomes with putative pro-dopamine regulator KB220, compared to treatment as usual.  Blum K, Lott L, Baron D, Smith DE, Badgaiyan RD, Gold MS.  J Syst Integr Neurosci. 2020 May 30;7:10.15761/JSIN.1000…

Enhanced Intranasal Absorption of Naltrexone by Dodecyl Maltopyranoside: Implications for the Treatment of Opioid Overdose.  Krieter P, Gyaw S, Chiang CN, Crystal R, Skolnick P.   J Clin Pharmacol. 2019;59(7):947-957. doi:10.1002/jc…

Cognitive performance of patients with opioid use disorder transitioned to extended-release injectable naltrexone from buprenorphine: Post hoc analysis of exploratory results of a phase 3 randomized controlled trial.  Kosten T, Aharonovich E…

Letter To The Editor - Drug Eruption After Sustained Release Naltrexone Pellet Implantation -- Editöre Mektup - Yavaş Salınımlı Naltrekson İmplant Uygulaması Sonrası Gelişen İlaç Erüpsiyonu. Ak S, Can Gürel Ş.  Turk Psikiyatri Derg. 2020…

Potential uses of naltrexone in emergency department patients with opioid use disorder.  Bradley ES, Liss D, Carreiro SP, Brush DE, Babu K.  Clin Toxicol (Phila). 2019;57(9):753-759. doi:10.1080/15563650.2019.1583342 https://www.ncbi.nl…